Citizen Petitions Come Under Fire In Pharma War

Law360, New York (July 6, 2006, 12:00 AM EDT) -- As generic drug makers continue to wrestle for their share of the pharmaceutical industry, the practice of filing citizen petitions has been attacked, with critics accusing brand name drug makers of exploiting the tool to unfairly shut generics out of the marketplace.

Some members of Congress, including Senator Trent Lott and Senator Debbie Stabenow, have alleged that the brand name drug industry has subverted the citizen petition process in yet another attempt to stave off generic competition.

Citizen requests, filed with the U.S. Food and Drug...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.